Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

401
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
401
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

443
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
443
Glaucoma: Overview01:25

Glaucoma: Overview

519
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
519

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uveitis Associated with Conventional Cigarette Smoking and E-Cigarette Use: A Narrative Review.

Medicina (Kaunas, Lithuania)·2026
Same author

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Neurology·2026
Same author

A Novel Virtual Reality-Based System for Measuring Deviation Angle in Strabismus: A Prospective Study.

Diagnostics (Basel, Switzerland)·2025
Same author

Acupuncture Safety in Taiwan.

Medical acupuncture·2025
Same author

Virtual Reality-Based Screening Tool for Distance Horizontal Fusional Vergence in Orthotropic Young Subjects: A Prospective Pilot Study.

Life (Basel, Switzerland)·2025
Same author

Impact of long-term statin therapy on age-related macular degeneration: A nationwide population-based study.

British journal of clinical pharmacology·2025

Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways
05:26

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Published on: April 12, 2024

1.3K

Acupuncture as Adjuvant Therapy for Glaucoma: Protocol for a Randomized Controlled Trial.

Yi-Fang Liao1,2, Yu-Chen Lee1,2, Hui-Ju Lin3,4

  • 1Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan.

JMIR Research Protocols
|October 8, 2024
PubMed
Summary

This study investigates acupuncture as a complementary therapy for glaucoma patients. Preliminary data is expected by December 2025 to assess acupuncture

Keywords:
acupunctureadjunctive therapyadjuvant therapyconventional treatmentdisease progressionefficacyglaucomaintraocular pressureopen-angle glaucomaophthalmic disordersopticoptic neuropathyoptical coherence tomography

More Related Videos

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

719
A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

19.4K

Related Experiment Videos

Last Updated: Jun 11, 2025

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways
05:26

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways

Published on: April 12, 2024

1.3K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

719
A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
09:26

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

19.4K

Area of Science:

  • Ophthalmology
  • Neurology
  • Integrative Medicine

Background:

  • Glaucoma is a progressive optic neuropathy requiring lifelong management.
  • Conventional treatments aim to slow optic nerve decline.
  • Acupuncture is explored as a complementary therapy to enhance glaucoma treatment effectiveness.

Purpose of the Study:

  • To evaluate acupuncture as an adjunctive therapy for glaucoma in a single-center randomized control trial.
  • To assess the effectiveness of acupuncture in managing glaucoma.
  • To explore the potential of acupuncture in reducing intraocular pressure.

Main Methods:

  • A randomized controlled trial with 50 primary open-angle glaucoma patients.
  • Participants assigned to either ophthalmic acupuncture with "De Qi" or minimum stimulation control.
  • Weekly treatments for 6 sessions, with assessments at baseline, during treatment, and at 3-month follow-up.

Main Results:

  • Participant recruitment began June 28, 2023.
  • Ten participants enrolled for feasibility testing.
  • Preliminary data anticipated by December 2025.

Conclusions:

  • The trial employs rigorous methods to evaluate acupuncture's clinical efficacy for glaucoma.
  • Comprehensive outcome measures will provide insights into acupuncture's role as an adjunctive therapy.
  • Findings may inform future clinical treatment guidelines for glaucoma management.